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Abstract
Background: Systemic immune response to injury plays a key role in the pathophysiological mechanism of blunt
trauma. We tested the hypothesis that increased blood interleukin-6 (IL-6) levels of blunt trauma patients on
emergency department (ED) arrival are associated with poor clinical outcomes, and investigated the utility of rapid
measurement of the blood IL-6 level.
Methods: We enrolled 208 consecutive trauma patients who were transferred from the scene of an accident to a
level I trauma centre in Japan and admitted to the intensive care unit (ICU). Blood IL-6 levels on ED arrival were
measured by using a rapid measurement assay. The primary outcome variable was prolonged ICU stay (length of
ICU stay > 7 days). The secondary outcomes were 28-day mortality, probability of survival and Abbreviated Injury
Scale (AIS) scores.
Results: Patients with prolonged ICU stay had significantly higher blood IL-6 levels on ED arrival than the patients
without prolonged ICU stay (P < 0.0001). The receiver-operating characteristic curves produced an area under the
curve of 0.75 (95 % confidence interval [CI], 0.66–0.84; P < 0.0001) for prolonged ICU stay. The patients who had
increased blood IL-6 levels on ED arrival had increased 28-day mortality (P = 0.021) and decreased probability of
survival (P < 0.0001). The AIS scores for the thorax, abdomen, extremity, and external body regions independently
correlated with blood IL-6 levels (unstandardized coefficients [95 % CI] for the thorax: 23.8 [12.6–35.1]; P < 0.0001;
abdomen: 42.7 [23.8–61.7]; P < 0.0001; extremity: 19.0 [5.5–32.4]; P = 0.0060; external body regions: 62.9 [13.2–112.7];
P = 0.030); the standardized coefficients for the thorax (0.27) and abdomen (0.28) were larger than those for the
extremity (0.18) and external body regions (0.15).
Conclusions: Increased blood IL-6 level on ED arrival was significantly associated with prolonged length of
ICU stay. Blood IL-6 level on ED arrival independently correlated with the AIS scores for the abdomen and
thorax, and, to a lesser extent, those for the extremity and external body regions. The rapid measurement of
blood IL-6 level on ED arrival can be utilized as a fast screening tool to improve assessment of injury severity
and prediction of clinical outcomes in the initial phase of trauma care.
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Background
Systemic immune response to injury plays a key role
in the pathophysiological mechanism of blunt trauma
[1, 2]. Inflammatory mediators such as tumour necro-
sis factor (TNF) alpha and interleukin-6 (IL-6) are re-
leased into the bloodstream from immune cells after
recognition of damage-associated molecular patterns from
injured tissues [1, 2]. The exaggerated inflammatory
response after trauma potentially causes development of
multiorgan dysfunctions (MODs) and prolongs length of
intensive care unit (ICU) stay, which lead to increased
mortality, morbidity, and medical costs [1, 3–6]. Early
identification of high-risk patients is crucial to improve
trauma care [7, 8].
Blood IL-6 levels in human trauma have been studied
[9–14]. Gebhard et al. serially measured blood IL-6
levels in patients with major trauma during the first 24 h
of trauma and were the first to report the significant
correlation between blood IL-6 levels during the early
phase of trauma (up to 12 h after hospital admission)
and injury severity score (ISS), suggesting a potential
utility of IL-6 level as an early biomarker of injury sever-
ity [9]. Subsequent IL-6 studies in patients with trauma
revealed a significant association between elevated blood
IL-6 levels during the early phase and development of
MODs [10–13]. However, the association between blood
IL-6 levels during the early phase of trauma and length
of ICU stay has been rarely tested, and only a few studies
demonstrated the association between blood IL-6 levels
and altered mortality from injury [13, 14]. Furthermore,
despite investigations on the association between blood
IL-6 level and ISS [9, 12, 14], the relationship between
blood IL-6 levels and Abbreviated Injury Scale (AIS)
score has been rarely analysed. Moreover, rapid IL-6
measurement systems including point-of-care testing are
currently available for clinical practice [15]; however the
investigation on potential utility of the point-of-care
testing for IL-6 in blunt trauma remains insufficient.
Thus, we tested the hypothesis that increased blood IL-
6 levels of blunt trauma patients on emergency depart-
ment (ED) arrival are associated with poor clinical out-
comes, and investigated the potential utility of rapid
measurement of the blood IL-6 level in the initial phase of
trauma care. We chose length of ICU stay as the primary
outcome variable, and 28-day mortality and probability of
survival according to Trauma and Injury Severity Score
(TRISS) [16] as secondary outcome variables. We further
investigated the association between the AIS scores for
the six body regions and the blood IL-6 levels. We studied
222 consecutive patients with trauma who were trans-
ferred from the scene of the accident to a level I trauma
centre in Japan and measured IL-6 levels by performing
rapid measurement assays of blood samples on the arrival
of the patient to the ED of the trauma centre.
Methods
Patients
The current observational study was prospectively
conducted. In this study, 222 consecutive trauma pa-
tients who were transferred from the scene of the
accident to the Senshu Trauma and Critical Care Center
(level I trauma centre, Osaka, Japan) between March
2014 and December 2014 were included. Of these
patients, 2 incurred burns, 2 incurred penetrating trau-
mas, and 10 did not require ICU admission were ex-
cluded from the study population. Thus, 208 patients
with blunt trauma who were admitted to the ICU were
evaluated in the study. The institutional review board
approved the study.
Measurement and definition
Blood IL-6 levels were measured with a rapid measure-
ment system (Ray-Fast, Toray, Tokyo, Japan) in the ED
of the trauma centre by using 200-μL whole blood
samples, which were left over after use for initial blood
gas analysis on the arrival of the patient to the ED. The
rapid measurement system, a compact device for point-
of-care testing (width 30 cm, length 42 cm, height
22 cm; weight 15 kg) that includes a chip and all
reagents. It took 19 min to provide IL-6 levels automat-
ically after loading cartridges with the whole blood
samples to the rapid measurement system through
microbead-based fluorescence enzyme immunoassay.
For the present study, prolonged ICU stay was defined
as an ICU stay of longer than 7 days [17, 18]. Patients
discharged alive from the ICU within 7 days were assigned
to the “ICU stay ≤ 7 days” group, while the remaining
patients were assigned to the “ICU stay > 7 days” group.
Trauma severity scores, including AIS score, ISS, Revised
Trauma Score, and probability of survival according to the
TRISS model, were determined [19, 20]. Prehospital time
was defined as the interval from the 911-call receipt to ED
arrival [21].
Statistical analysis
We primarily analysed the association between blood IL-6
levels on ED arrival and prolonged ICU stay. Blood IL-6
levels were compared by using a Mann–Whitney U or
Kruskal-Wallis test. The area under the curve (AUC) of
the receiver-operating characteristic (ROC) curves of the
blood IL-6 levels in relation to prolonged ICU stay or
28-day mortality was analysed. Patients were catego-
rized into tertiles of TRISS, and blood IL-6 levels
among the tertiles were compared.
The relationship between AIS scores and blood IL-6
levels was analysed by using multiple linear regression by
the following equation: blood IL-6 levels = b1 (Head AIS
score) + b2 (Face AIS score) + b3 (Thorax AIS score) + b4
(Extremity AIS score) + b5 (External AIS score) + C.
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Differences were considered significant if the two-
tailed p value was 0.05. Analyses were performed by
using the SPSS statistical software (SPSS, version 20,
Chicago, IL).
Results
In baseline characteristics, the patients who had prolonged
ICU stay (length of ICU stay > 7 days) were older and had
higher severity scores than the patients who had an ICU
stay of ≤7 days (Table 1). The patients with prolonged
ICU stay had significantly higher blood IL-6 levels on ED
arrival than the patients without prolonged ICU stay
(P < 0.0001; Fig. 1a). The ROC curves yielded an AUC of
0.75 (95 % confidence interval [CI], 0.66–0.84; P < 0.0001)
for prolonged ICU stay (Fig. 1b).
The patients who died within 28 days had significantly
higher blood IL-6 levels than the patients who survived
(P = 0.021; Fig. 2a). The patients who had a lower
probability of survival according to the TRISS model
had significantly increased blood IL-6 levels on ED
arrival (P < 0.0001; Fig. 2b). The AUC of blood IL-6
levels on ED arrival for 28-day mortality was 0.76
(95 % CI, 0.49–1.02; P = 0.021; Fig. 1b).
We tested for the association between blood IL-6
levels on ED arrival and severity scores. The patients
who had severe ISS had significantly increased blood
IL-6 levels on ED arrival (Fig. 3). ISS or TRISS sig-
nificantly correlated with the blood IL-6 levels on ED
arrival (P < 0.0001; Pearson correlation coefficient,
0.459 [ISS], −0.453 [TRISS]).
We further tested for the association between the AIS
scores for the six body regions and the blood IL-6 levels
by using multiple linear regression analysis. The AIS
scores for the thorax, abdomen, extremity, and external
Table 1 Baseline characteristic and clinical outcomes of the patients
ICU stay > 7 days ICU stay≤ 7 days
(n = 48) (n = 160) P
Age, years 58 (43–71) 40 (20–59) 0.0002
Sex, % male 77.1 73.1 0.58
Mechanism of injury, n (%) 0.50
Road injury 32 (66.7) 110 (68.8)
Fall 13 (27.1) 32 (20.0)
Compression/machinery 1 (2.1) 11 (6.9)
Other 2 (4.2) 7 (4.4)
Prehospital time, min 43 (23–54) 39 (29–53) 0.17
AIS score≥ 3, n (%)
Head and neck 31 (64.6) 39 (24.4) <0.0001
Face 3 (6.3) 1 (0.6) 0.039
Thorax 19 (39.6) 26 (16.3) 0.0006
Abdomen 9 (18.8) 4 (2.5) 0.0003
Extremity 17 (35.4) 20 (12.5) 0.0003
External 0 (0) 0 (0) -
ISS 26 (17–35) 7 (1–14) <0.0001
RTS 6.4 (4.1–7.8) 7.8 (7.8–7.8) <0.0001
TRISS Ps, % 0.75 (0.32–0.90) 0.99 (0.96–0.99) <0.0001
Intervention, n (%) 30 (62.5) 19 (11.9) <0.0001
Surgical 19 (39.6) 13 (8.1)
Endovascular 2 (4.2) 6 (3.8)
Both 9 (18.8) 0 (0)
Length of ICU stay, days 14 (8–25) 2 (2–3) <0.0001
Length of hospital stay, days 41 (19–52) 4 (2–10) <0.0001
28-day mortality, n (%) 7 (14.6) 0 (0) <0.0001
Prehospital time was defined as the interval from the 911-call receipt to ED arrival
Immediate intervention was defined as surgical or endovascular intervention for haemostasis within 24 h after hospital arrival. Data are presented as median
(interquartile range). P values were calculated by using the chi-square test, Fisher exact test, or Mann–Whitney U test
AIS Abbreviated Injury Scale, ISS Injury Severity Score, RTS Revised Trauma Score, TRISS Trauma Injury Severity Score, Ps probability of survival
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body regions independently correlated with blood IL-6
levels (unstandardized coefficient [95 % CI] for the thorax:
23.8 [12.6–35.1], P < 0.0001; abdomen: 42.7 [23.8–
61.7], P < 0.0001; extremity: 19.0 [5.5–32.4], P = 0.0060;
external body regions: 62.9 [13.2–112.7], P = 0.030;
Table 2); the standardized coefficients for the thorax and
abdomen were larger than those for the extremity and
external body regions (Table 2).
Discussion
In the present study of blunt trauma, the patients who had
increased blood IL-6 levels on ED arrival had prolonged
Fig. 1 Panel a. Blood interleukin-6 (IL-6) levels on emergency department arrival. The patients who were discharged alive from the intensive care
unit within 7 days had lower blood IL-6 levels than the patients who did not survive (P < 0.0001). Error bars indicate the standard error of the
mean. P values were calculated by using the Mann–Whitney U test. Panel b. Receiver-operating characteristic curve analysis. The area under the
curve of the receiver-operating characteristic curves of the blood IL-6 levels was 0.76 for prolonged ICU stay (95 % confidence interval
[CI], 0.67–0.84; P < 0.0001) and 0.76 for 28-day mortality (95 % CI, 0.50–1.02; P = 0.021)
Fig. 2 Blood IL-6 levels on emergency department arrival. Panel a. Twenty-eight-day mortality. The patients who died within 28 days had
significantly higher blood IL-6 levels than the patients who survived (P = 0.021). Error bars indicate the standard error of the mean. P values
were calculated by using the Mann–Whitney U test. Panel b. Probability of survival according to trauma and injury severity score. The patients who
had lower probability of survival according to Trauma and Injury Severity Score (TRISS) had higher blood IL-6 levels on emergency department arrival
(low vs. middle vs. high, P < 0.0001; low vs. middle, P < 0.05; low vs. high, P < 0.0001; middle vs. high, P < 0.001). Probability of survival in
tertiles (median [interquartile range]): low tertile group (0.859 [0.652–0.924]), middle tertile group (0.983 [0.969–0.991]), and high tertile
group (0.997 [0.996–0.997]). Error bars indicate the standard error of the mean. P values were calculated by using the Kruskal-Wallis test
with Dunn’s multiple comparison test
Taniguchi et al. World Journal of Emergency Surgery  (2016) 11:6 Page 4 of 7
ICU stay, increased 28-day mortality, and decreased prob-
ability of survival. Blood IL-6 levels independently corre-
lated with the AIS scores for the abdomen and thorax, and,
to a lesser extent, the AIS scores for the extremity and
external body regions in the multivariate linear regression.
The association between blood IL-6 levels and length
of ICU stay in patients with trauma has been rarely
investigated, whereas the associations between increased
blood IL-6 levels in early phase of trauma and the devel-
opment of MODs has been reported in previous studies
[10, 11, 13]. Frink et al. investigated whether blood TNF,
IL-1, IL-6, IL-8, and IL-10 levels predicted the devel-
opment of MODs in patients with major traumas and
revealed that blood IL-6 level was the best parameter
to predict MODs development among these humeral
mediators (n = 143; blood IL-6 levels at day 1: AUC,
0.874; 95 % CI, 0.811–0.937) [13]. Likewise, Jastrow
et al. and Cuschieri et al. reported high AUC values
for blood IL-6 levels in the early phase of trauma for
predicting MODs (Jastrow et al.: n = 48; blood IL-6
levels 4–8 h after ICU admission: AUC, 0.816; Cuschieri
et al.: n = 79; blood IL-6 levels during 12 h: AUC, 0.749,
95 % CI, 0.643–0.855) [10, 11]. Considering that the
development of MODs is linked with prolonged
length of ICU stay [4, 5], our study result on the as-
sociation between blood IL-6 levels and prolonged
ICU stay concurred with the results of the previous
studies on the development of MODs.
Previous studies revealed that patients who did not
survive from trauma had increased blood IL-6 levels
Fig. 3 Blood interleukin-6 (IL-6) levels on emergency department arrival according to injury severity score. The patients who had severe
injury severity scores had significantly increased blood IL-6 levels on emergency department arrival (P < 0.0001). Error bars indicate the
standard error of the mean. P values were calculated by using the Kruskal-Wallis test
Table 2 Association between blood IL-6 levels on emergency department arrival and Abbreviated Injury Scale scores in the
multivariate logistic regression analysis
Unstandardized coefficient (95 % Confidence interval) Standardized coefficient P
AIS
Head/neck 6.3 (−3.9 to 16.6) 0.08 0.22
Face −1.3 (−25.7 to 23.1) −0.07 0.91
Thorax 23.8 (12.6–35.1) 0.27 <0.0001
Abdomen 42.7 (23.8–61.7) 0.28 <0.0001
Extremity 19.0 (5.5–32.4) 0.18 0.0060
External 62.9 (13.2–112.7) 0.15 0.030
Unstandardized and standardized coefficients were calculated by using multiple linear regression analysis
AIS Abbreviated Injury Scale
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during the early phase [13, 14]. Frink et al. reported a
high AUC value for blood IL-6 levels at day 1 for
predicting mortality in patients with multiple injuries
(n = 21/143 [death/total]; blood IL-6 levels at day 1:
AUC, 0.858; 95 % CI, 0.759–0.956) [13]. In accord-
ance with these results, the association between blood
IL-6 level on ED arrival and increased 28-day mortal-
ity or decreased probability of survival was observed
in the present study of blunt trauma.
The correlations of the blood IL-6 levels in the early
phase of trauma with ISSs had been well documented in
the previous studies and was consistently observed in the
present study (correlation coefficient, 0.46–0.61) [9, 12, 14].
As the ISS is the sum of squared AIS scores for three most
severely different injured body regions, we further analysed
the correlation between blood IL-6 level and AIS score in
each body region. To the best of our knowledge, this is the
first report on the correlation between blood IL-6 level on
ED arrival and the AIS score of each body region that used
multiple regression analysis. Our study showed that the
AIS scores for the thorax, abdomen, extremity, and external
body regions were independently correlated with blood IL-
6 levels and that the AIS score for the thorax or abdomen
had a greater effect on the blood IL-6 levels. The different
body regions are composed of different types of cells, which
may have contributed to the different effect on the blood
IL-6 levels of the patients with blunt trauma.
The patients of traumatic brain injury (TBI) had in-
creased IL-6 levels in blood and cerebrospinal fluid
(CSF) during the early phase of trauma [22–24]. As the
IL-6 concentrations were much higher in CSF than in
blood [22, 23], IL-6 is likely to be derived from cells in-
side the blood–brain barrier, which restricts the move-
ment of IL-6, resulting in the difference between blood
and CFS IL-6 levels. A previous study suggested no cor-
relation between blood IL-6 levels on hospital admission
and head injury severity [25]. In accordance with this,
we found no significant correlation between blood IL-6
levels on ED arrival and AIS score for the head in the
present study.
The blood IL-6 levels of trauma patients peaked
around 6 h after hospital arrival [9, 10]. The results of
previous studies of the association between blood IL-6
levels within 4–12 h after admission and severity scores
or altered clinical outcomes highlighted the potential
utility of blood IL-6 measurements in clinical practice
[9–11, 14]. However, the timing of 4–12 h after hospital
arrival is not optimal for trauma physicians to measure
blood IL-6 levels as a point-of-care testing and to utilize
for predicting severity or clinical outcomes in clinical
practice because detailed medical examinations, estima-
tion of injury severity, or even immediate surgical/radio-
logical interventions have already been completed at
that time. By contrast, patient arrival to the ED may be a
more practical timing to utilize blood IL-6 level as an
adjunctive clinical tool to predict outcome and improve
trauma care. In our study, we measured IL-6 levels by
using a rapid point-of-care testing assay in a small
amount (200 μL) of whole blood samples, which were
initially taken for blood gas analysis on ED arrival. It
took 19 min to provide IL-6 values automatically after
loading cartridges with the whole blood to the measure-
ment system; in most cases, we obtained blood IL-6
levels within 30 min before assessing injury severity by
performing detailed medical examinations. Thus blood
IL-6 level on ED arrival measured by using the rapid
measurement system can be utilized as a fast screen-
ing tool to improve assessment of injury severity and
prediction of clinical outcomes in the initial phase of
trauma care.
This study has some limitations. Although non-
survivors or patients with low probability of survival
according to TRISS had significantly higher blood IL-
6 levels than the survivors or patients with high prob-
ability of survival, the sample size of non-survivors
was small and the comparison of blood IL-6 levels on
ED arrival between the survivors and non-survivors
was underpowered.
Conclusions
Increased blood IL-6 levels on ED arrival was signifi-
cantly associated with prolonged length of ICU stay in
patients with blunt trauma. Blood IL-6 levels on ED
arrival independently correlated with AIS scores for the
abdomen and thorax, and, to a lesser extent, the AIS
scores for the extremity and external body regions.
These findings suggest the potential utility of the rapid
measurement of blood IL-6 level on ED arrival as a fast
screening tool to improve assessment of injury severity
and prediction of clinical outcomes in the initial phase
of trauma care.
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